OTC Artificial Tears Market Size is projected to reach USD 6.79 Billion by 2030, growing at a CAGR of 5.10%: Straits Research

The global OTC artificial tears market had a revenue share of USD 4,565 million in 2021, expected to advance to USD 6,797 million growing at a CAGR of 5.10% during the forecast period. North America is most likely to hold the largest market share during the forecast period growing at a CAGR of 4.57%.

Pune, INDIA


New York, United States, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The application of artificial tears protects and hydrates mucous membranes and alleviates dryness and irritation of the eyes. Artificial Tears is a specially formulated ocular lubricant. These eye drops can treat dry eyes brought on by aging, specific medications, a medical condition, eye surgery, or environmental factors such as wind and smog. Artificial tears alleviate the discomfort, irritation, and burning caused by dry eyes. Over-the-counter (OTC) artificial tears are sold directly to consumers without a prescription. In addition to lubricating the eyes, some artificial tears promote eye healing, while others reduce tear evaporation. Artificial tears may also contain thickening agents that prolong the solution's contact with the eye's surface.

The global market for over-the-counter (OTC) artificial tears is primarily driven by an increase in the geriatric population, an alarming rise in the prevalence of dry eye syndrome (DES), and an increase in eye surgeries, which increases the demand for artificial tear drops for post-surgery management. In addition, changes in lifestyle habits, such as prolonged exposure to digital displays and an increase in smartphone addiction, cause dry eye syndrome, which increases the demand for artificial tears and drives the market growth. In addition, as the number of eye surgeries increases, so does the requirement for artificial tear drops for post-operative care.


Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/otc-artificial-tears-market/request-sample 


Growing Prevalence of DES and Allergic Conjunctivitis and Growth in Geriatric Population to Drive the Global OTC Artificial Tears Market

The availability of various dosage forms of over-the-counter artificial tears for the prevention, diagnosis, and treatment of dry eye syndrome is one of the key factors driving the market growth. In 2019, the American Academy of Ophthalmology (AAO) reported that dry eye syndrome affected approximately 3.2 million women and 1.68 million men. Dry eye syndrome can result in infection, blurred vision, and sensitivity if left untreated for an extended period. In addition, it is estimated that the incidence rate of distance vision impairment is four times higher in low- and middle-income countries than in high-income countries.

Eye drops, solutions, gels, suspension, and ointments are among the many formulations of artificial tears available over-the-counter for treating dry eye syndrome. Patients' medications are distributed by the distribution channel, including hospitals, online pharmacies, and drug stores. Furthermore, allergic conjunctivitis is one of the most common causes of eye inflammation. 40% of the global population was diagnosed with allergic conjunctivitis in 2021, according to StartPearls. Due to the rapid spread of allergic conjunctivitis and dry eye syndrome, the market for over-the-counter artificial tears is expanding.

The aging global population drives the expansion of the global market for OTC artificial tears. The elderly have the highest prevalence of eye diseases such as dry eye, glaucoma, age-related macular degeneration, cataract, and presbyopia. According to data published by the United Nations, there were approximately 703 million individuals aged 65 and older in 2019. Globally, the proportion of the over-65 geriatric population increased from 6% in 1990 to 9% in 2019. Between 5% and 30% of the elderly suffer from dry eyes. An increase in the elderly population drives the expansion of the market for over-the-counter artificial tears.


Report Scope

Report MetricDetails
Market SizeUSD 6.79 Billion by 2030
CAGR5.10% (2022-2030)
Historical Data2019-2020
Base Year2021
Forecast Period2022-2030
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments CoveredProduct Type, Container Type, Formulation, Application, Distribution Channel, Region
Geographies CoveredNorth America, Europe, Asia-Pacific, LAME and Rest of the World
Key Companies Profiled/VendorsAbbVie, Inc., Akorn, Inc., Alcon, Bausch & Lomb, Johnson & Johnson, Ocusoft, Santen Pharmaceutical Co. Ltd, Similasan Corporation, Sun Pharmaceutical Industries Limited , Ursapharm Arzneimittel GmbH
Key Market OpportunitiesGrowing Research and Development by Major Players
Key Market DriversGrowing Prevalence of DES and Allergic Conjunctivitis
Growth in Geriatric Population

Buy Now Full Report @ https://straitsresearch.com/buy-now/otc-artificial-tears-market 


Regional Insights

North America is most likely to hold the largest market share during the forecast period growing at a CAGR of 4.57%. Due to the increasing prevalence of geriatrics, the expansion of health care infrastructure, the introduction of sophisticated products, and the presence of market leaders, North America will continue to dominate the market in terms of revenue during the forecast period. The increasing prevalence of dry eye syndrome and advances in ophthalmology R&D are expected to fuel market expansion.

In addition, it is anticipated that the increase in the number of eye surgeries will contribute to the region's dominance during the study period. For instance, the Centers for Disease Control and Prevention (CDC) reported that over 4,2 million Americans aged 40 and older had legal blindness or low vision. In the United States, cataracts and glaucoma are the leading causes of blindness.

Europe will have the second-largest market share of USD 2,008 million, growing at a CAGR of 5.25% by 2030. The rise in the number of cataract surgeries, the presence of key market players, technological advancements in the healthcare industry, and the adoption of contact lenses are viewed as the primary growth drivers of the market. Europe's increasing technological advancement in ophthalmology is the primary market driver. Due to the rapid adoption of artificial tears in Europe, the over-the-counter market for artificial tears is expanding rapidly. As cataract surgery becomes more prevalent in Europe, demand for over-the-counter (OTC) artificial tears to alleviate itching, irritation, redness, and burning sensations increases.

Asia-Pacific will grow at the highest CAGR during the forecast period. Due to a rise in the elderly population, the number of cataract and glaucoma surgeries, and environmental pollution, the Asia-Pacific market is anticipated to experience substantial growth during the forecast period. Many patients in China and India suffer from dry eye, making them highly attractive investment markets. Additionally, the increase in the number of patients diagnosed with dry eye syndrome and the rise in awareness programs for the prevention and management of the ocular disease is anticipated to provide growth opportunities for the manufacturer of novel artificial tear products and boost the expansion of the global market for over-the-counter artificial tears.

Increment in the geriatric population, increase in cataract and glaucoma surgeries and advances in R&D drive market growth. Environmental pollution is one of the leading causes of ocular disease, which in turn causes irritation and dry eye syndrome. In addition, China's pollution index of 81.12 indicates an increase in environmental pollution. Those who reside in areas with a high risk of air pollution are more likely to suffer from dry eye disease.


Key Highlights

  • The global OTC artificial tears market size had a revenue share of USD 4,565 million in 2021, expected to advance to USD 6,797 million growing at a CAGR of 5.10% during the forecast period. 
  • Based on product type, the solution type will have the largest share in the OTC artificial tears market, growing at a CAGR of 5.13% during the forecast period.
  • Based on container type, the Plastic Multi-Dose Container is anticipated to have the largest share during the forecast period advancing a CAGR of 5.35%.
  • Based on formulation, preservative based will have the largest market share growing at the highest CAGR of 5.21% during the forecast period.
  • Based on the application, the dry eye syndrome will hold the largest market share during the forecast period, advancing a CAGR of 4.63%.
  • Based on the distribution channel, the drug stores & retail pharmacies are expected to hold the largest market share during the forecast period growing at a CAGR of 4.87%.
  • Based on regional analysis, North America is most likely to hold the largest market share during the forecast period growing at a CAGR of 4.57%.


Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/otc-artificial-tears-market/request-sample 


Competitive Players in the Market

  • AbbVie, Inc.
  • Akorn, Inc.
  • Alcon
  • Bausch & Lomb
  • Johnson & Johnson
  • Ocusoft
  • Santen Pharmaceutical Co. Ltd
  • Similasan Corporation
  • Sun Pharmaceutical Industries Limited 
  • Ursapharm Arzneimittel GmbH


Global OTC Artificial Tears Market: Segmentation
By Product Type

  • Solution
  • Ointment
  • Emulsion
  • Gel
  • Spray Solution
  • Suspensions

By Container Type

  • Plastic Single-Dose Container
  • Plastic multi-dose containers
    • Preservative-Free System
    • Preserved System
  • Spray
    • Preservative-Free System
    • Preserved System

By Formulation

  • Preservative Based
  • Non-Preservative Based

By Application

  • Dry Eye Syndrome
  • Allergies
  • Infections
  • UV & Blue Light Protection
  • Contact Lens Moisture Retention
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Drug Store & Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Middle-East
  • North Africa


TABLE OF CONTENT

  1. Introduction
    1. Market Definition
    2. Market Scope
  2. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  3. Market Overview
    1. Report Segmentation & Scope
    2. Value Chain Analysis: OTC Artificial Tears Market
    3. Key Market Trends
      1. Drivers
      2. Restraints
      3. Opportunities
    4. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
    5. Market Share Analysis
  4. Product Type Overview
    1. Introduction
      1. Market Size & Forecast
    2. Solution
      1. Market Size & Forecast
    3. Ointment
      1. Market Size & Forecast
  5. Container Type Overview
    1. Introduction
      1. Market Size & Forecast
    2. Plastic Single-Dose Container
      1. Market Size & Forecast
    3. Spray
      1. Market Size & Forecast
  6. Regional Overview
    1. Introduction
      1. Market Size & Forecast
    2. America
      1. North America
      2. U.S.
        1. By Product Type
        2. By Container Type
      3. Canada
        1. By Product Type
        2. By Container Type
      4. Mexico
        1. By Product Type
        2. By Container Type
      5. Latin America
        1. By Product Type
        2. By Container Type
    3. Europe
      1. Market Size & Forecast
      2. Germany
        1. By Product Type
        2. By Container Type
      3. France
        1. By Product Type
        2. By Container Type
      4. U.K.
        1. By Product Type
        2. By Container Type
      5. Italy
        1. By Product Type
        2. By Container Type
      6. Spain
        1. By Product Type
        2. By Container Type
      7. Rest of Europe
        1. By Product Type
        2. By Container Type
    4. Asia Pacific
      1. Market Size & Forecast
      2. Japan
        1. By Product Type
        2. By Container Type
      3. China
        1. By Product Type
        2. By Container Type
      4. Australia
        1. By Product Type
        2. By Container Type
      5. India
        1. By Product Type
        2. By Container Type
      6. South Korea
        1. By Product Type
        2. By Container Type
      7. Rest of Asia-Pacific
        1. By Product Type
        2. By Container Type
    5. Middle East & Africa
      1. Market Size & Forecast
      2. Saudi Arabia
        1. By Product Type
        2. By Container Type
      3. South Africa
        1. By Product Type
        2. By Container Type
      4. Kuwait
        1. By Product Type
        2. By Container Type
      5. Rest of Middle East & Africa
        1. By Product Type
        2. By Container Type
  7. Company Profile
    1. AbbVie Inc
      1. Company Overview
      2. Financial Performance
      3. Recent Developments
      4. Product Portfolio
    2. Akorn Inc
      1. Company Overview
      2. Financial Performance
      3. Recent Developments
      4. Product Portfolio
    3. Alcon
      1. Company Overview
      2. Financial Performance
      3. Recent Developments
      4. Product Portfolio
  8. Conclusion & Recommendation
  9. Acronyms & Abbreviations


Table of Content and Figure @ https://straitsresearch.com/report/otc-artificial-tears-market/toc 
 


Market News

  • In 2022, Akorn, Inc. announced the completion of its sale of seven branded ophthalmic products to Théa Pharma.
  • In 2022, Bausch & Lomb announced the launch of Reviveä Custom Soft Contact lenses.


News Media

Dry Eye Syndrome Market: Europe is expected to witness strong growth for dry eye syndrome market during the forecast period


Have a Look at the Related Research Report

Artificial Tears Market: Information by Type (Cellulose Derived Tears, Glycerin Derived Tears), Delivery Method (Eye Drops, Ointments) and Applications (Dry Eyes Treatment) —Forecast Till 2026 

Contact Lenses Market: Information by Usage (Daily Wear), Design (Multifocal), Material (Gas Permeable), Application (Corrective) Distribution Channel, and Region — Forecast till 2029

Eye Health Supplements Market: Information by Supplement Category (Antioxidants), Therapeutic Domain (Age-Related Macular Degeneration), Product Type, and Region — Forecast till 2029
                            
Global Eyewear Market: Information by Product Type (Spectacles, Sunglasses, and Contact lenses), Distribution Channel (Online Store and Retail Store), and Regions-Forecast Till 2030

Diabetic Retinopathy Market: Information By Type (Proliferative DR and Diabetic Macular Edema), Treatment Type (Anti VEGF Drug, Steroid Implants) and Regional Outlook—Forecast Till 2026


About Straits Research Pvt. Ltd.

StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.


For more information on your target market, please contact us below:
Phone: +1 646 480 7505 (the U.S.)
+91 8087085354 (APAC)
+44 208 068 9665 (the U.K.)
Email: sales@straitsresearch.com

Follow Us: LinkedIn | Facebook | Instagram | Twitter